The achievement of individual goals selected from the Patient Disability Scale reflected a functional benefit in the ABO group at week 20; in addition, modest improvements were noted in the Caregiver Burden Scales and the Patient Disability Scale; however, these measures did not reach statistical significance.
← all excerpts
Systematic literature review of abobotulinumtoxinA in clinical trials for adult upper limb spasticity.
1
—
—